BioAnalytix Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Debt - PPP

BioAnalytix General Information

Description

Provider of analytic services intended for biotherapeutic companies. The company works with leading pharmaceutical companies to develop and apply advanced analytic technologies, methods and data, enabling clients to accelerate biologic therapeutics from development through the market.

Contact Information

Website
www.bioanalytixinc.com
Formerly Known As
BioAnalytix Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Media and Information Services (B2B)
Other Industries
Biotechnology
Acquirer
ProtaGene
Corporate Office
  • 790 Memorial Drive
  • Cambridge, MA 02139
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAnalytix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - PPP 30-Apr-2020 Completed
3. Merger/Acquisition 11-Apr-2019 00.000 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Oct-2013 $3.75M $4.61M 00.00 Completed Generating Revenue
1. Early Stage VC (Series A) 15-Aug-2012 $858K $858K 00.000 Completed Startup
To view BioAnalytix’s complete valuation and funding history, request access »

BioAnalytix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series A 000,000 00.000000 00 00.00 00.00 00 00.00 00.00
To view BioAnalytix’s complete cap table history, request access »

BioAnalytix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of analytic services intended for biotherapeutic companies. The company works with leading pharmaceutical compa
Media and Information Services (B2B)
Cambridge, MA
00.000
000000000 -

00000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
Basel, Switzerland
00000 As of 0000
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioAnalytix Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lonza Group Corporation Basel, Switzerland 00000 00000 000000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

BioAnalytix Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

BioAnalytix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3353555-A1 Method for determining the in vivo comparability of biologic drug and a reference drug Inactive 25-Sep-2015 00000000000
US-20190073452-A1 Method for determining the in vivo comparability of a biologic drug and a reference drug Inactive 25-Sep-2015
US-20160266141-A1 Mass spectrometry-based method for identifying and maintaining quality control factors during the development and manufacture of a biologic Inactive 03-Oct-2013 00000000000
EP-3114476-A2 Mass spectrometry-based method for identifying and maintaining quality control factors during the development and manufacture of a biologic Inactive 03-Oct-2013 00000000000
EP-3114476-A4 Mass spectrometry-based method for identifying and maintaining quality control factors during the development and manufacture of a biologic Inactive 03-Oct-2013 G01N33/6848 0
To view BioAnalytix’s complete patent history, request access »

BioAnalytix Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Relativity Capital PE/Buyout Minority 000 0000 000000 0
To view BioAnalytix’s complete investors history, request access »

Ready to get started?

Request a free trial

BioAnalytix FAQs

  • When was BioAnalytix founded?

    BioAnalytix was founded in 2012.

  • Who is the founder of BioAnalytix?

    Kirtland Poss is the founder of BioAnalytix.

  • Where is BioAnalytix headquartered?

    BioAnalytix is headquartered in Cambridge, MA.

  • What industry is BioAnalytix in?

    BioAnalytix’s primary industry is Media and Information Services (B2B).

  • Is BioAnalytix a private or public company?

    BioAnalytix is a Private company.

  • What is BioAnalytix’s current revenue?

    The current revenue for BioAnalytix is 000000.

  • How much funding has BioAnalytix raised over time?

    BioAnalytix has raised $4.61M.

  • Who are BioAnalytix’s investors?

    Relativity Capital has invested in BioAnalytix.

  • Who are BioAnalytix’s competitors?

    Lonza Group is a competitor of BioAnalytix.

  • When was BioAnalytix acquired?

    BioAnalytix was acquired on 30-Apr-2020.

  • Who acquired BioAnalytix?

    BioAnalytix was acquired by ProtaGene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »